Laparoscopic Heller’s cardiomyotomy for achalasia cardia-a case series with review of literature
DOI:
https://doi.org/10.18203/2349-2902.isj20240176Keywords:
Achalasia cardia, Laparoscopic cardio myotomy, Manometry, OGD scopyAbstract
Laparoscopic Heller’s cardio myotomy has almost completely replaced the open procedure performed for achalasia cardia. Several studies have suggested that long-term results with surgery for achalasia cardia are better than a medical line of management. In this retrospective study, we outline our experience with laparoscopic cardio myotomy over 15 years. Also, we compare our results with those of other interventional modalities which are known therapeutic options for achalasia cardia. We identified 10 patients (4 females and 6 males) operated upon by a single surgeon from 2008 to 2023, at our institution. The age range was 16-48 years. All patients had undergone oesophago-gastro-duodenoscopy (OGD scopy), upper gastro-intestinal (UGI) manometry and contrast enhanced computerised tomography (CECT) of the lower chest and upper abdomen. The patients were analysed for age, sex, symptoms, pre-operative evaluation, the exact procedure performed (Heller’s+Toupet’s vs Heller’s+Dorr’s), morbidity/mortality and functional outcomes. They were also reviewed to examine the length of stay, length of procedure, complications and recurrent symptoms on follow-up.
References
Mirsharifi A, Ghorbani AA, Mirsharifi R, Jafari M, Fattah N, Mikaeli J, et al. Laparoscopic Heller Myotomy for Achalasia: Experience from a Single Referral Tertiary Center. Middle East J Dig Dis. 2019;11(2):90-97.
Li MY, Wang QH, Chen RP, Su XF, Wang DY. Pathogenesis, clinical manifestations, diagnosis, and treatment progress of achalasia of cardia. World J Clin Cases. 2023;11(8):1741-52.
Swanström LL. Achalasia: treatment, current status and future advances. Korean J Intern Med. 2019;34(6):1173-80.
Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160-74.
Ates F, Vaezi MF. The Pathogenesis and Management of Achalasia: Current Status and Future Directions. Gut Liver. 2015;9(4):449-63.
Kato R, Nakajima K, Takahashi T, Tanaka K, Miyazaki Y, Makino T, et al. Validation of new Japanese classification system for esophageal achalasia. Esophagus. 2019;16(3):252-257.
Ghoshal UC, Das Chakraborty SB, Singh R. Pathogenesis of achalasia cardia. World J Gastroenterol. 2012;18(24):3050-7.
Storch WB, Eckardt VF, Wienbeck M, Eberl T, Auer PG, Hecker A, et al. Autoantibodies to Auerbach's plexus in achalasia. Cell Mol Biol (Noisy-le-grand). 1995;41(8):1033-8.
Moonen A, Annese V, Belmans A, Bredenoord AJ, Bruley des Varannes S, Costantini M, et al. Long-term results of the European achalasia trial: a multicentre randomised controlled trial comparing pneumatic dilation versus laparoscopic Heller myotomy. Gut. 2016;65(5):732-9.
Riccio F, Costantini M, Salvador R. Esophageal Achalasia: Diagnostic Evaluation. World J Surg. 2022;46(7):1516-21.
Pomenti S, Blackett JW, Jodorkovsky D. Achalasia: Diagnosis, Management and Surveillance. Gastroenterol Clin North Am. 2021;50(4):721-36.
Sato H, Takahashi K, Mizuno KI, Hashimoto S, Yokoyama J, Terai S. A clinical study of peroral endoscopic myotomy reveals that impaired lower esophageal sphincter relaxation in achalasia is not only defined by high-resolution manometry. PLoS One. 2018;13(4):e0195423.
Holmstrom AL, Campagna RJ, Carlson DA, Pandolfino JE, Soper NJ, Hungness ES, et al. Comparison of preoperative, intraoperative, and follow-up functional luminal imaging probe measurements in patients undergoing myotomy for achalasia. Gastrointest Endosc. 2021;94(3):509-514.
Jacobs JW Jr, Richter JE. Functional lumen imaging probe and Heller myotomy: solves the dysphagia issue, but the resulting GERD is still a mystery. Gastrointest Endosc. 2021;94(3):515-6.
Licurse MY, Levine MS, Torigian DA, Barbosa EM Jr. Utility of chest CT for differentiating primary and secondary achalasia. Clin Radiol. 2014;69(10):1019-26.
Vaezi MF, Pandolfino JE, Yadlapati RH, Greer KB, Kavitt RT. ACG Clinical Guidelines: Diagnosis and Management of Achalasia. Am J Gastroenterol. 2020;115(9):1393-411.
Ochuba O, Ruo SW, Alkayyali T, Sandhu JK, Waqar A, Jain A, et al. Endoscopic Surveillance in Idiopathic Achalasia. Cureus. 2021;13(8):e17436.
Yamaguchi D, Tsuruoka N, Sakata Y, Shimoda R, Fujimoto K, Iwakiri R. Safety and efficacy of botulinum toxin injection therapy for esophageal achalasia in Japan. J Clin Biochem Nutr. 2015;57(3):239-43.
Chadalavada P, Thota PN, Raja S, Sanaka MR. Peroral Endoscopic Myotomy as a Novel Treatment for Achalasia: Patient Selection and Perspectives. Clin Exp Gastroenterol. 2020;13:485-95.
Ramchandani M, Pal P. Achalasia Cardia: A Comprehensive Review. EMJ Gastroenterol. 2020;9(1):106-117.
Chen H, Calderon LF, Shah R, Zheng W, Xia L, Wang W, et al. Simultaneous Examination of Eosinophil Infiltration in Esophageal Mucosa and Muscle in Patients with Achalasia: Direct Biopsy of the Esophageal Muscle at Per-oral Endoscopic Myotomy. Dig Dis Sci. 2022;67(1):170-76.
Tustumi F, De Sousa JHB, Dornelas NM, Rosa GM, Steinman M, Bianchi ET. The Mechanisms for the Association of Cancer and Esophageal Dysmotility Disorders. Med Sci (Basel). 2021;9(2):32.
Allescher HD, Storr M, Seige M, Gonzales-Donoso R, Ott R, Born P, et al. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up. Endoscopy. 2001;33(12):1007-17.
Eckardt VF, Gockel I, Bernhard G. Pneumatic dilation for achalasia: late results of a prospective follow up investigation. Gut. 2004;53(5):629-33.
Abdelfatah MM, Calderon LF, Koldhekar A, Kapil N, Noll A, Shah R, et al. Long-term Outcome of Per-oral Endoscopic Myotomy Performed in the Endoscopy Unit with Trainees. Surgical Laparoscopy Endoscopy Percutaneous Tech. 2021;32(1):114-8.
